Cargando…
Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report
BACKGROUND: Family history is one of the risk factors for pancreatic cancer. It is suggested that patients with pancreatic cancer who have a familial history harbor germline pathogenic variants of BRCA1 and/or BRCA2 (BRCA1/2), PALB2, or ATM. Recently, some germline variants of familial pancreatic ca...
Autores principales: | Abe, Kodai, Ueki, Arisa, Urakawa, Yusaku, Kitago, Minoru, Yoshihama, Tomoko, Nanki, Yoshiko, Kitagawa, Yuko, Aoki, Daisuke, Kosaki, Kenjiro, Hirasawa, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792085/ https://www.ncbi.nlm.nih.gov/pubmed/33413558 http://dx.doi.org/10.1186/s13053-020-00160-z |
Ejemplares similares
-
Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome
por: Yoshihama, Tomoko, et al.
Publicado: (2020) -
Hereditary pancreatic cancer
por: Abe, Kodai, et al.
Publicado: (2021) -
Genomic analysis of familial pancreatic cancers and intraductal papillary mucinous neoplasms: A cross‐sectional study
por: Abe, Kodai, et al.
Publicado: (2022) -
Molecular Features and Clinical Management of Hereditary Gynecological Cancers
por: Ueki, Arisa, et al.
Publicado: (2020) -
GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes
por: Yoshihama, Tomoko, et al.
Publicado: (2018)